Matches in SemOpenAlex for { <https://semopenalex.org/work/W2775890264> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2775890264 endingPage "532" @default.
- W2775890264 startingPage "522" @default.
- W2775890264 abstract "Abstract Momelotinib is a Janus kinase 1/2 inhibitor in clinical development for the treatment of myelofibrosis. Two phase 1 open‐label, parallel‐group, adaptive studies were conducted to evaluate the pharmacokinetics of a single 200‐mg oral dose of momelotinib in subjects with hepatic or renal impairment compared with healthy matched control subjects with normal hepatic or renal function. Plasma pharmacokinetics of momelotinib and its major active metabolite, M21, were evaluated, and geometric least‐squares mean ratios (GMRs) and associated 90% confidence intervals (CIs) for impaired versus each control group were calculated for plasma exposures (area under concentration–time curve from time 0 to ∞ [AUC ∞ ] and maximum concentration) of momelotinib and M21. There was no clinically significant difference in plasma exposures of momelotinib and M21 between subjects with moderate or severe renal impairment or moderate hepatic impairment and healthy control subjects. Compared with healthy control subjects, momelotinib AUC ∞ was increased (GMR, 197%; 90%CI, 129%–301%), and M21 AUC ∞ was decreased (GMR, 52%; 90%CI, 34%–79%) in subjects with severe hepatic impairment. The safety profile following a single dose of momelotinib was similar between subjects with hepatic or renal dysfunction and healthy control subjects. These pharmacokinetic and safety results indicate that dose adjustment is not necessary for momelotinib in patients with renal impairment or mild to moderate hepatic impairment. In patients with severe hepatic impairment, however, the dose of momelotinib should be reduced." @default.
- W2775890264 created "2018-01-05" @default.
- W2775890264 creator A5002922217 @default.
- W2775890264 creator A5015324983 @default.
- W2775890264 creator A5038720672 @default.
- W2775890264 creator A5042879298 @default.
- W2775890264 creator A5059327926 @default.
- W2775890264 creator A5088930540 @default.
- W2775890264 date "2017-12-28" @default.
- W2775890264 modified "2023-09-27" @default.
- W2775890264 title "Pharmacokinetics and Safety of Momelotinib in Subjects With Hepatic or Renal Impairment" @default.
- W2775890264 cites W1550111394 @default.
- W2775890264 cites W1853295728 @default.
- W2775890264 cites W1978853026 @default.
- W2775890264 cites W1980568348 @default.
- W2775890264 cites W2010293026 @default.
- W2775890264 cites W2026424254 @default.
- W2775890264 cites W2049145190 @default.
- W2775890264 cites W2060123467 @default.
- W2775890264 cites W2061289307 @default.
- W2775890264 cites W2061377922 @default.
- W2775890264 cites W2071990094 @default.
- W2775890264 cites W2144664431 @default.
- W2775890264 cites W2521045502 @default.
- W2775890264 cites W2762112922 @default.
- W2775890264 cites W2545745979 @default.
- W2775890264 doi "https://doi.org/10.1002/jcph.1050" @default.
- W2775890264 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29283448" @default.
- W2775890264 hasPublicationYear "2017" @default.
- W2775890264 type Work @default.
- W2775890264 sameAs 2775890264 @default.
- W2775890264 citedByCount "5" @default.
- W2775890264 countsByYear W27758902642018 @default.
- W2775890264 countsByYear W27758902642020 @default.
- W2775890264 countsByYear W27758902642021 @default.
- W2775890264 crossrefType "journal-article" @default.
- W2775890264 hasAuthorship W2775890264A5002922217 @default.
- W2775890264 hasAuthorship W2775890264A5015324983 @default.
- W2775890264 hasAuthorship W2775890264A5038720672 @default.
- W2775890264 hasAuthorship W2775890264A5042879298 @default.
- W2775890264 hasAuthorship W2775890264A5059327926 @default.
- W2775890264 hasAuthorship W2775890264A5088930540 @default.
- W2775890264 hasConcept C112705442 @default.
- W2775890264 hasConcept C126322002 @default.
- W2775890264 hasConcept C126894567 @default.
- W2775890264 hasConcept C159641895 @default.
- W2775890264 hasConcept C71924100 @default.
- W2775890264 hasConcept C76318530 @default.
- W2775890264 hasConcept C90924648 @default.
- W2775890264 hasConceptScore W2775890264C112705442 @default.
- W2775890264 hasConceptScore W2775890264C126322002 @default.
- W2775890264 hasConceptScore W2775890264C126894567 @default.
- W2775890264 hasConceptScore W2775890264C159641895 @default.
- W2775890264 hasConceptScore W2775890264C71924100 @default.
- W2775890264 hasConceptScore W2775890264C76318530 @default.
- W2775890264 hasConceptScore W2775890264C90924648 @default.
- W2775890264 hasFunder F4320308573 @default.
- W2775890264 hasIssue "4" @default.
- W2775890264 hasLocation W27758902641 @default.
- W2775890264 hasLocation W27758902642 @default.
- W2775890264 hasOpenAccess W2775890264 @default.
- W2775890264 hasPrimaryLocation W27758902641 @default.
- W2775890264 hasRelatedWork W2011948815 @default.
- W2775890264 hasRelatedWork W2046146392 @default.
- W2775890264 hasRelatedWork W2061653966 @default.
- W2775890264 hasRelatedWork W2137001434 @default.
- W2775890264 hasRelatedWork W2392413698 @default.
- W2775890264 hasRelatedWork W2393010518 @default.
- W2775890264 hasRelatedWork W2400700397 @default.
- W2775890264 hasRelatedWork W2547209859 @default.
- W2775890264 hasRelatedWork W2994250685 @default.
- W2775890264 hasRelatedWork W4320032780 @default.
- W2775890264 hasVolume "58" @default.
- W2775890264 isParatext "false" @default.
- W2775890264 isRetracted "false" @default.
- W2775890264 magId "2775890264" @default.
- W2775890264 workType "article" @default.